Search

everythinglearnresearchcommunity

for

Search:↓

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

The hydrogel patch helps heal diabetic wounds by releasing a healing agent in response to harmful molecules and improving skin regeneration.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Chemical exposure may contribute to the rise in atopic diseases and needs more research.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

A new one-step test can quickly identify skin cancer during surgery.

Topical glucocorticoids thin the skin and change collagen structure.

The study suggests that hypothyroidism may cause alopecia areata.